Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

6.7K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

QSAR-Based Strategies for Selective-HDAC6 Inhibitor Development: A Detailed Review.

Current medicinal chemistry·2026
Same author

Nano-icilin-driven TRPM8 activation elicits immunogenic exosomes with antitumor effects.

Nanomedicine (London, England)·2025
Same author

Investigating Functional and Folding Stability of an Engineered <i>E. coli</i> L-asparaginase Harboring Y176F/S241C Mutations.

Advanced pharmaceutical bulletin·2024
Same author

Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation.

Future medicinal chemistry·2024
Same author

Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries.

BioImpacts : BI·2024
Same author

Application of Carbon-based Nano Adsorbents in the Extraction of Amphetamines from Urine Samples.

Combinatorial chemistry & high throughput screening·2024

Related Experiment Video

Updated: Jul 17, 2025

GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins
11:22

GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins

Published on: October 29, 2013

42.5K

Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells.

Ali Akbar Alizadeh1, Saba Rasouli2,3, Omid Jamshidi Kandjani1

  • 1Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Advanced Pharmaceutical Bulletin
|August 30, 2023
PubMed
Summary

This study presents a recombinant DNA method for producing teduglutide, a treatment for short bowel syndrome (SBS). The method successfully expressed, purified, and confirmed the functionality and structure of teduglutide for potential large-scale manufacturing.

Keywords:
Affinity chromatographyPeptideRecombinant technologySBSSize exclusion chromatographyTeduglutide

More Related Videos

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

30.3K
Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
12:03

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration

Published on: January 22, 2014

33.6K

Related Experiment Videos

Last Updated: Jul 17, 2025

GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins
11:22

GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins

Published on: October 29, 2013

42.5K
High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

30.3K
Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
12:03

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration

Published on: January 22, 2014

33.6K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Drug Development

Background:

  • Short bowel syndrome (SBS) is a malabsorptive condition.
  • Teduglutide is an FDA-approved therapeutic for SBS.
  • Efficient production methods are crucial for drug accessibility.

Purpose of the Study:

  • To develop a recombinant DNA technology approach for teduglutide production.
  • To establish a scalable method for manufacturing teduglutide.

Main Methods:

  • Cloning the teduglutide gene into a pGEX-2T vector with a Factor Xa cleavage site.
  • Overexpressing the GST-teduglutide fusion protein in E. coli BL21 (DE3).
  • Purification using glutathione sepharose affinity chromatography, on-column Factor Xa digestion, and size exclusion chromatography.

Main Results:

  • Successfully expressed and purified teduglutide with high structural integrity confirmed by circular dichroism and mass spectroscopy.
  • Demonstrated teduglutide's biological activity through in vitro assays, showing significant induction of Caco2 cell proliferation.
  • Achieved a primarily alpha-helical structure (>50%) for the produced teduglutide.

Conclusions:

  • The developed recombinant DNA technology approach enables successful expression, purification, and functional validation of teduglutide.
  • The experimental-scale method is suitable for adaptation to pilot-scale and industrial-scale teduglutide production.
  • This study provides a foundation for efficient and scalable manufacturing of teduglutide for SBS treatment.